An analysis of factors that influence patient preference of third‐line therapy for overactive bladder-Reference-Cited by-同舟云学术

An analysis of factors that influence patient preference of third‐line therapy for overactive bladder

Published:2022-09-14 Issue:8 Volume:41 Page:1906-1913
ISSN:0733-2467
Container-title:Neurourology and Urodynamics
language:en
Short-container-title:Neurourology and Urodynamics

Author:

Kapur Anjali¹^ORCID,Harandi Arshia Aalami²,Cohen Tal³,Ruan Heng¹,Dabrowski Colin⁴,Anderson Rebecca⁵^ORCID,Hwang Kuemin⁶,Lee Edwin⁷,Weissbart Steven¹^ORCID,Kim Jason¹

Affiliation:

1. Department of Urology Stony Brook University Medical Center Stony Brook New York USA

2. Albert Einstein College of Medicine Bronx New York USA

3. The New York Institute of Technology College of Osteopathic Medicine Glen Head New York USA

4. Staten Island University Hospital Staten Island New York USA

5. Department of Surgery, Urology Division, Rutgers New Jersey Medical School Newark New Jersey USA

6. Department of Urology, Houston Methodist Hospital Houston Texas USA

7. Renaissance School of Medicine at Stony Brook University Stony Brook New York USA

Publisher

Wiley

Subject

Urology,Neurology (clinical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/nau.25046

Reference16 articles.

1. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction

2. National Community Prevalence of Overactive Bladder in the United States Stratified by Sex and Age

3. Prevalence and burden of overactive bladder in the United States

4. Long-term prospective randomized study comparing two different regimens of oxybutynin as a treatment for detrusor overactivity

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost Analysis of Oral Phenazopyridine vs Intravesical Lidocaine for Preprocedural Analgesia for Intradetrusor OnabotulinumtoxinA Injections;Urology Practice;2024-09

2. New TENSI+ Device for Transcutaneous Posterior Tibial Nerve Stimulation: A Prospective, Multicentre, Post-market Clinical Study;European Urology Focus;2024-05

3. Shifts in patient preference of third‐line overactive bladder therapy after introduction of the implantable tibial nerve stimulator;Neurourology and Urodynamics;2024-02-23

4. Overactive Bladder: the Patient Perspective;Current Bladder Dysfunction Reports;2024-01-08